CW April 2003
Volume 12Issue Number 4 April 2003 ISSN 10593802 FDA Approves New Drug to Combat Chemotherapy-Induced EmesisAn agent that inhibits a specific nerve transmission that stimulates the ?vomiting center? is approved by the Federal Drug Administration (FDA). This new agent, aprepitant (Emend) is highly effective in the control of chemotherapy-induced delayed nausea and vomiting.
Go to Previous Page Go to Next Page Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW April 2003Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
